Clinical Trial Update: Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial [Phase 3]

View source ↗

Summary

Open-label extension trial update for arimoclomol in amyotrophic lateral sclerosis (Phase 3) has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Arimoclomol (arimoclomol)

Snippet

Sponsor: ZevraDenmark | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: TERMINATED | Results posted: 2023-08-24